CLINICAL DATA PGxHEALTH DIVISION
PGxHealth
     
 
Clinical Data, Inc. Announces Public Offering of Common Stock
PGxHealth
About PGxHealthDrug DevelopmentFAMILION TestingMedia InfoContact Us

Drug Development  
   
Biomarkers  
   
FAMILION Testing  
   
PGxPredict™:RITUXIMAB  
   
Licensing & Partnerships  
The Science and Technology
PGxHealth, a division of Clinical Data, Inc. is a biotechnology company that leverages its expertise in biomarker discovery and late-stage drug development to deliver first-in-class or best-in-class therapeutics, as well as genetic and pharmacogenomic tests to detect serious diseases and help predict drug safety, tolerability and efficacy.

PGxHealth is leveraging its biomarker discovery and commercial expertise to guide development of our drug pipeline. The division leads the commercial and laboratory efforts supporting our FAMILION® family of genetic tests for inherited heart disease that can cause potentially lethal heart conditions. In addition, PGxHealth supports the development and commercialization of pharmacogenetic tests to predict drug response under the PGxPredict brand.
 
Familion
PGxPredict:RITUXIMAB
Customer Service
1-877-2-PGXHEALTH (877-274-9432)